Feldner, Reardon, Babson, & Dixon, 2008) , and depression (Otto, Pollack, Fava, Uccello, & Rosenbaum , 1995) . Com pared w ith patients w ith other anxiety disorders or nonclinical controls, patients w ith panic disorder and/or agoraphobia usually have the highest AS scores (Deacon & Abramowitz, 2006; Taylor et al., 2007) .
AS is not a unitary construct as originally proposed by Reiss (1991) . Actually, numerous studies suggest that AS is best conceptualized as a hierarchical construct that is com posed of three lower order dimensions: Somatic Concerns, Social Concerns, and Cognitive Concerns (Taylor et al., 2007; Zinbarg, Barlow, & Brown, 1997) . These lower order dimensions seem to be of different impact in the develop ment and maintenance of anxiety problems as each dimension is associated with thematically related anxiety psychopa thology. For example, the factor Somatic Concerns is most strongly correlated with phenomena pertaining to panic and agoraphobia. Zinbarg, Brown, Barlow, and Rapee (2001) found that this factor is the only one of the three lower order factors that contributes to relations w ith fear responses to laboratory panic challenges. Moreover, measures of this factor correlate substantially w ithbody vigilance (Zvolensky & Forsyth, 2002 ) and a diagnosis of panic disorder and/or agoraphobia (Taylor et al., 2007) . In contrast, the AS factor Social Concerns is substantially correlated w ith trait m ea sures covering interpersonal behavior such as fear of nega tive evaluation and extraversión (Kemper, Ziegler, & Taylor, 2009 ) and a diagnosis of social phobia (Taylor et al., 2007) . Finally, the Cognitive Concerns factor shows mod erate to high correlations w ith measures of depression (Armstrong et al., 2006) and seems to be a relatively non specific measure of general distress (Taylor, Koch, Woody, & McLean, 1996) .
The m ajority of studies conducted during the past 25 years focus on the latent dimensionality of the AS con struct. These studies suggest that AS is a multidimensional and hierarchically organized construct w ith one general fac tor and three to four lower order factors which seem differen tially related to various forms of psychopathology. Besides this dimensional approach some researchers have applied other approaches in AS structural research to test a conjec ture first formulated by Taylor (1999) and later adopted and elaborated by Bernstein et al. (2007) . These authors suggest that the latent structure of AS might not be dimensional but categorical or a mixture thereof and that only one of two postulated latent classes is uniquely associated with vulner ability for anxiety psychopathology. If this conjecture was empirically supported, its impact on our understanding of the role AS plays in the etiology of psychopathology would be strong. Bernstein and colleagues applied elaborate statis tical methods, for example, coherent cut kinetic taxometric methods (Waller & Meehl, 1998) , a mixture of coherent cut kinetic taxometric and factor analytic methods, and factor mixture modeling (Muthén, 2008) , to support their claim.
They were able to present findings from demographically and geographically diverse samples (for an overview, see Bernstein et al., 2010) corroborating their claim that "AS has a taxonic (two-class) latent structure, and that each class has a unique multidimensional factor structure" (Bernstein et al., 2010, p. 527) . However, their claim concerning the categorical two-class structure is not uncontroversial. Their position is currently challenged by several researchers who could not find evidence for the two postulated substantive AS classes (Asmundson, Weeks, Carleton, Thibodeau, & Fetzner, 2011; Broman-Fulks et al., 2008; Broman-Fulks et al., 2010; Kemper, 2010) . This issue is far from being settled as both positions seem supported by comprehensive evidence.
However, measures of the construct that were developed in the past (for an overview see Peterson & Plehn, 1999) rest on the assumption that the latent AS structure is dimen sional. Betw een 1986 and 2009, the A nxiety Sensitivity Index (ASI; Reiss et al., 1986) was the most frequently used measure of the construct (Kemper, 2010) . Because of criti cism pertaining to aspects of its psychometric quality the ASI was revised twice. In 1998, Taylor and Cox proposed the Anxiety Sensitivity Index-Revised (ASI-R) as a broad measure of AS and its lower order dimensions. Because of its unstable factor structure (cf. Taylor et al., 2007) another revision took place. The most recent version, the Anxiety Sensitivity Index-3 (ASI-3) was proposed by Taylor and colleagues in 2007.
The 18-item ASI-3 assumes a hierarchical three-factor structure of the construct and yields measures of Somatic Concerns (e.g., "It scares me when my heart beats rapidly"), Social Concerns (e.g., "It is important for me not to appear nervous"), and Cognitive Concerns (e.g., "W hen I cannot keep my mind on a task, I worry that I might be going crazy") for the first-order level, and Global AS for the second-order level. Some studies confirming the psychomet ric quality have been conducted so far using nonclinical sam ples. The three-factor hierarchic structure o f the ASI-3 was confirmed in several geographically diverse North American samples (Taylor et al., 2007) , thereby corroborat ing the consensus reached among AS researchers on the structure of the ASI (Zinbarg et al., 1997) . Invariance of the internal structure between different countries was supported (Kemper et al., 2009) . Further evidence concerning the con struct validity of the ASI-3 was obtained in these studies as well as in others (e.g., Osman et al., 2010) . Notably, the ASI-3 was found to be superior to its predecessors ASI and ASI-R. Taylor et al. (2007) demonstrated that the ASI-3 measures the construct more precisely-the ASI-3 has a higher reliability and construct validity than the ASI. In contrast to the ASI-R, the internal structure of the ASI-3 is stable across diverse samples. According to these results, the ASI-3 may be considered a reliable and valid measure of the most robust dimensions of the AS construct.
In the upcoming years, the ASI-3 might well become the standard tool of AS assessment. Thus, further research on its psychometric quality is necessary. The construct validity o f the ASI-3 was already demonstrated in several nonclinical samples (Kemper et al., 2009; Osman et al., 2010) . However, the question whether the ASI-3 is a useful assess ment tool in clinical psychology research and a feasible screening instrument in applied settings has been addressed only once so far. In their large psychometric study of the ASI-3, Taylor et al. (2007) also analyzed a subsample of patients. These authors obtained first evidence for the con struct validity of the ASI-3 in a clinical context by compar ing groups differing in primary diagnosis on ASI-3 subscale scores (criterion-related validity). To further advance knowledge on the usefulness of the ASI-3 for clinical research and assessment, we addressed different aspects of construct validity. Construct validity of the ASI-3 was assessed in two samples of patients w ith anxiety or mood disorders by (a) testing the three-factor hierarchical struc ture proposed by Taylor et al. (2007; factorial validity) , ( b) examining relations of ASI-3 scores with psychopathologyrelated constructs (convergent and discriminant validity), and ( c) comparing ASI-3 scores of patients with different clinical diagnoses (criterion-related validity; cf. Taylor et al., 2007) .
Four sets of theoretical expectations pertaining to the four scales yielded by the ASI-3, Somatic, Social, Cognitive Concerns, and Global AS, guided the validation process.
(1) The ASI-3 measure of Global AS (GAS) should differ entiate between patients w ith anxiety disorder and patients w ith nonanxiety disorders since patients with anxiety disor ders have elevated levels of AS compared w ith other patients or persons without a clinical diagnosis (Olatunji & W olitzky-Taylor, 2009 ).
Particularly, patients with panic disorder fear anxietyrelated sensations because of their assum ed aversive som atic consequences, for exam ple, heart attack. Thus (2) the Somatic Concerns subscale of the ASI-3 (SOM) should allow for a differentiation of patients with panic dis order and/or agoraphobia and patients with nonanxiety dis orders or other anxiety disorders (Taylor et al., 2007) . Moreover, substantial correlations of the SOM subscale w ith m easures o f body vigilance and sym ptom burden should be observable in clinical samples as ( a) high AS per sons indicate a higher vigilance for somatic symptoms in self-reports (Zvolensky & Forsyth, 2002) and (b) a higher interoceptive accuracy concerning diverse somatic symp toms and processes compared with persons w ith low AS (Richards & Bertram, 2000) .
The Social Concerns subscale of the ASI-3 (SOC) cap tures concerns and fear of social consequences of publicly observable anxiety reactions, for example, ridicule. Persons who experience problems in their interpersonal relationships, for example people who are shy, insecure, introverted, or socially avoidant, may be particularly prone to the fear that their anxiety symptoms could be observed and evaluated by others in a negative way. Thus, (3) substantial correlations should be obtained between SOC and measures of interper sonal problems, fear of negative evaluation, or social pho bia (cf. Kemper et al., 2009; Naragon-Gainey, 2010) .
The Cognitive Concerns subscale (COG) measures symptoms of anxiety that could lead to catastrophic cogni tive consequences: "Anxiety disorders have been found to be associated with particular forms of cognitive concerns" (Taylor et al., 2007, p. 185) . For example, panic disorder seems to be associated with strong fears of catastrophic consequences (e.g., loss of control) which might arise from cognitive phenomena such as derealization. Generalized anxiety disorder (GAD) was found to be associated with the harmful effects of uncontrollable worry ( cf. Taylor et al., 2007) . Patients with depressive episode seem particularly prone to another form of cognitive concerns-rumination (Nolen-Hoeksema, 2000) . Taken together, these results suggest that many anxiety and mood disorders involve dif ferent forms of cognitive concerns. Findings from the AS literature corroborate this suggestion by reporting substan tial correlations between AS Cognitive Concerns and m ea sures of anxiety or mood disorders or elevated subscale scores of these diagnostic groups (Deacon & Abramowitz, 2006; Naragon-Gainey, 2010; Otto et al., 1995; Rector, Szacun-Shimizu, & Leybman, 2007; Taylor et al., 2007) . Thus ( 4) we expected to find substantial differences between patients diagnosed with an anxiety or mood disorder com pared with patients without such a diagnosis (nonanxiety nonmood disorder). Moreover, we expected substantial cor relations between COG and measures of depression symp toms (Naragon-Gainey, 2010).
Method

Participants
Two clinical samples were used in the following analyses. Sample 1 consisted of 514 patients receiving cognitivebehavioral or psychodynamic treatment at a psychothera peutic inpatient unit in Germany (cf. Watzke et al., 2010) . Patients who fulfilled the criteria for at least one mental dis order according to the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) Chapter V (World Health Organization, 1992) with a prim ary diagnosis o f neurotic, stress-related, and somatoform disorders (F41-49) or mood disorders (F30-39) were recruited. These clinical diagnoses were chosen for the present investigation as these patients are affected by elevated AS scores (Olatunji & W olitzky-Taylor, 2009 ). Sample 1 did not contain persons w ith diagnoses F I 0-19 as persons with a primary diagnosis related to substance abuse are not routinely treated at the clinic. Sample 1 was 73% female, with a mean age of 47 years (SD = 10 years). In term s of the International Standard Classification of Education, 44% had completed lower secondary education and 38% upper secondary education. A total of 21% were single, 46% were married, and the remaining were sepa rated, widowed, or divorced. In all, 55% received some form of psychopharmacological treatment ( antidepressants, anxiolytics, neuroleptics, etc.). All diagnoses were assessed clinically and were based on ICD-10 criteria (for details on the diagnostic process, see below). Primary diagnoses in terms of severity or relevance to treatm ent1 were the fol lowing: depressive disorders (F33.0-F33.9, n = 248), adjustment disorders (F43.2, n = 118), agoraphobia and panic disorder with/or without agoraphobia (F40.0, F41.0, n = 38), mixed anxiety-depression (F41.2, n = 17), somato form disorders (F45.1/3, n = 16), dysthymia (F34.1, n = 14), posttraum atic stress disorder (F43.1, n = 13), complex chronic pain disorder (F45.4, n = 13), generalized anxiety disorder (F41.1, n = 11), other specified neurotic disorders (F48.8, n = 9), social phobia (F40.1, n = 5), obsessivecompulsive disorder (F42.-, n = 6), other anxiety disorders (F41.8-9, n = 2), dissociative disorders (F44.-, n = 3), and bipolar disorder (F31.-, n = 1).
Sample 2 was composed of 75 outpatients of various psychotherapists in the Rhine-M ain M etropolitan Region of Germany receiving cognitive-behavioral treatment at the time of assessment. In total, 84% of the sample was female. M ean age of patients was 39 years (SD = 12 years). In all, 57% had completed lower secondary education and 43% upper secondary education. A lm ost h alf of the sample (49%) was married, 37% were single, and the remaining were separated or divorced. Inclusion criteria were the same as in Sample 1. Diagnoses were assessed clinically and were based on ICD-10 criteria. Prim ary diagnoses in term s of severity were as follows: depressive disorders (F33.0-F33.9, n = 35), panic disorder with/or without ago raphobia (F40.0, F41.0, n = 11), adjustment disorders (F43.2, n = 12), anxiety disorder-unspecified (F41.9, n = 9), posttraumatic stress disorder (F43.1, n = 2), generalized anxiety disorder (F41.1, n = 2), mixed anxiety depression (F41.2, n = 2), and specific phobia (F40.2, n = 2). To achieve more robust means, Sample 1 and Sample 2 were merged for further analyses.
Measures and Procedure
Sample 1 was recruited at the in-patient unit described above. The clinic is part of routine mental health care in Germany. About 90% of patients are referred to the clinic by a physician who works for the German pension or health insurance. The physician usually conducts unstructured clinical interviews, assigns a preliminary diagnosis, and forwards the diagnostic information to the clinic. The diag nostic process in the clinic is a systematic and standardized multistage procedure (cf. Watzke et al., 2010) . In the admis sion phase, patients complete a comprehensive question naire containing psychometric measures (outlined below) and questions concerning the patient's sociodemographics, medical and psychological condition, level of functioning, and well-being in various domains. Afterwards, the patient is assigned to a responsible psychotherapist who is an expe rienced diagnostician-a psychiatrist or psychologist who either completed a multiyear postgraduate professional training or is currently in training and works under supervi sion. He rediagnoses the patient based on ICD-10 symptom checklists (e.g., Hiller, Zaudig, & Mombour, 1996) , data from psychometric assessment, and diagnostic information forwarded by the referring physician. Up to five diagnoses are assigned starting with the most severe to the least severe. After 3 weeks of therapy, initial diagnoses are reviewed for accuracy in a staff meeting by a multiprofessional team of experienced diagnosticians including the director of the unit and the responsible psychotherapist among others. Confirmation or modification of initial diagnosis is based on a consensus decision among experts. By this systematic and standardized multistage diagnostic process-involving different experienced diagnosticians who integrate multiple data sources such as clinical interviews and psychometric measurement-a reliable diagnosis is ensured (cf. Watzke et al" 2010).
Psychometric assessment included several measures.2 The German adaptation (Kemper et al., 2009 ) of the ASI-3 (Taylor et al., 2007) was administered. To assess interper sonal behavior, the German adaptation (Horowitz, StrauB, & Kordy, 2000) (Laux, Glanzmann, Schaffner, & Spielberger, 1981 ; a = .90) of the State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch, & Lushene, 1970) was used to assess interindividual differences in anxiety. Symptom burden was assessed w ith the SCL-14 (Harfst et al., 2002 ; a = .87), a b rief G erm an version of the Symptom Check L ist-9 0 -R (Derogatis, Rickels, & Rock, 1976) . To m easure bodily discom fort in four differ ent domains (exhaustion, rheumatism, abdom inal pain, and heart complaints) the Giessen Subjective Com plaints List (GBB-24; Brâhler & Scheer, 1995; a = .93 ) was administered.
Participants in Sample 2 received most of the psycho metric measures administered in Sample 1. They completed the ASI-3, CES-D, and the STAI. Additionally, they were asked to fill out a German adaptation (Vormbrock & Neuser, 1983 ; a = .83) of the Fear of Negative Evaluation Scale (FNE, W atson & Friend, 1969) and the Body Vigilance Scale (BVS; Schmidt, Lerew, & Trakowski, 1997; a = .83) . The FNE measures the disposition to fear potential negative evaluation by others. Fear of negative evaluation is thought to be a core cognitive factor of social anxiety and social phobia (e.g., Clark & Wells, 1995) . Body vigilance, as assessed by the BVS, denotes consciously attending to internal bodily sensations and perturbations. This normally adaptive process has been found to be exag gerated in patient samples (Schmidt et al., 1997) . As in Sample 1, participants filled out the questionnaire before the commencement of treatment.
The study protocol described above was approved by the local human ethics committee. All patients who participated in the present research received a complete description of the study and provided written informed consent prior to data collection.
Statistical Analysis
Data analysis was conducted in four steps: (1) A t first, descriptive statistics for the general scale and three sub scale scores of the ASI-3 as well as reliability coefficients (Cronbach's alpha) were computed and evaluated accord ing to Nunnally and Bernstein (1994; a > .70 = acceptable, a > .80 = good). Afterward, several aspects of construct validity of the ASI-3 were tested.
(2) Factorial validity was investigated using a structural equation modeling approach. The three-factor hierarchical model confirmed by Taylor et al. (2007) for the ASI-3 and by Kemper et al. (2009) for its German adaptation in essen tially nonclinical samples was fitted to the combined clini cal sample using robust maximum likelihood estimation in M Plus 6. M odel fit assessment was based on fit indices rec ommended by Beauducel and W ittmann (2005) . These authors favor the SRMR (standardized root mean square residual) and the RM SEA (root mean square error of approximation) particularly with regard to latent trait mod els. Assessment of model fit was based on criteria proposed by Hu and Bentler (1999) .
(3) Group differences in ASI-3 scores of patients diag nosed with specific mental disorders were tested according to theoretical expectations outlined above. Because of the low frequency of some disorders in the merged sample, we formed four groups based on primary ICD-10 diagnosispanic disorder/agoraphobia (panic disorder with or without agoraphobia), other anxiety disorder (social phobia, GAD, and PTSD), mood disorder (depressive episode and dysthymia), nonanxiety or nonm ood disorder (somatoform and adjustment disorder)-to test our theoretical expectations. Only diagnoses with n > 5 were classified into these groups. Diagnoses that could not be classified unambiguously were excluded from the analysis, for example, mixed anxietydepression (F43.1).
To consider comorbidity and the potential role of the secondary diagnosis, we performed analyses of variance (ANOVA) w ith the prim ary diagnosis (panic disorder/ agoraphobia, other anxiety disorder, mood disorder, non anxiety or nonmood disorder), the secondary diagnosis (no secondary diagnosis, panic disorder/agoraphobia, other anxiety disorder, mood disorder, nonanxiety or nonmood disorder, substance use disorder), and the primary diagnosis by secondary diagnosis interaction as predictors, and the relevant ASI-3 subscales as criteria. The interaction was included to reveal any contribution of specific combina tions of primary and secondary diagnoses to the prediction. Because of the imbalanced design-caused by unequal cell sizes-there are different choices concerning the type of sums of squares for the ANOVAs. We used so-called Type I sums of squares, in which the contribution of the predic tors in a model are tested sequentially. Because of its impor tance, the primary diagnosis was entered before the secondary diagnosis; the interaction was entered last. In this way it is possible to answer the question whether the sec ondary diagnosis adds in any way to the prediction of the ASI scores, over and above the prediction already possible by the prim ary diagnosis. Subsequently, follow-up tests (a = .05) were conducted and effect sizes (Hedges' [1981] g) were calculated.
(4) Correlational analyses were conducted to further examine theoretical expectations concerning convergent and discriminant validity of the ASI-3 scales. To demon strate the differential validity of subscales, correlation coefficients between ASI-3 subscales and psychopathologyrelated measures were also tested for substantial differences w ith methods proposed for the comparison of correlated correlation coefficients (Meng, Rosenthal, & Rubin, 1992; Steiger, 1980) .
Results
Descriptive Statistics and Reliability
Descriptive statistics and reliability coefficients are pre sented in Table 1 . In Sample 1, ASI-3 total scores ranged from 0 to 72, in Sample 2 from 5 to 72, respectively. Scores for the Social Concerns subscale ranged from 0 to 24 in Sample 1 and from 1 to 24 in Sample 2, respectively. Scores for Cognitive Concerns and Somatic Concerns ranged from 0 to 24 in Sample 1 and Sample 2 as well. Both samples showed nearly exactly the same means and standard devia tions. A multivariate analysis o f variance o f the ASI-3 scales did not yield any significant differences between 
Factorial Validity
The three-factor hierarchical model of the ASI-3 is depicted in Figure 1 . No exact model fit was achieved = 583.0, df= 133, p < .001, SRMR = .07, RMSEA = .07 [.07-.08], CFI = .90). M odification indices (Mis) were inspected to identify potential sources of model misfit. Inspection of the M is pointed to several residual correlations w ithin the Cognitive Concerns subscale. The three highest M is were found for the residuals of Item 2 ("When I cannot keep my mind on a task, I worry that I might be going crazy") and Item 5 ("It scares me when I am unable to keep my mind on a task"), residual correlation r = .39; Items 2 and 14 ("W hen my thoughts seem to speed up, I worry that I might be going crazy"), residual correlation r = .24; and Item 16 ("W hen I have trouble thinking clearly, I worry that there is something wrong with me") and Item 18 ("When my mind goes blank, I worry that there is something terribly wrong with me"), residual correlation r = .25. Apparently, these correlated residuals are not because of conceptual reasonsmisspecification of the model-but because of technical aspects of the ASI-3, that is, an overlap in wording of some items. Thus, we included these residual correlations in the model, thereby yielding an acceptable fit for the threefactor hierarchical model of the ASI-3 (x2 = 439.9, df= 130, p < .001, SRMR = .05, RM SEA = .06 [.05-.07], CFI = .94). All items had substantial loadings on their respective fac tors (.49 < X < .84) and lower order factors had high load ings on the higher order AS factor, SOM X = .69, SOC X = .85, and COG X = .96, supporting a global AS construct.
Convergent, Discriminant, and Criterion-Related Validity
Results are presented in order of the four theoretical expec tations described above: Table 2 . As expected, SOM scores were substantively associated with measures of self-reported body vigilance (r = .56, p < .01), and symptom burden (GBB, r = .37, p < .01; SCL, r = .42, p < .01). Moreover, cor relations with psychopathology-related measures differed across ASI-3 subscales supporting their differential validity. For example, correlations betw een BVS and ASI-3 subscales were sub stantially higher for SOM than for COG (t = 2.2, p < .05) and SOC (t = 2 .8 ,/) < .01). Some cor relations between ASI-3 subscales and measures of symptom burden were also significantly differ ent, for example, correlations of COG versus SOC with psychopathology-related measures were sub stantially higher for GBB (t = -4 .5 , p < .01) and for SCL-14 (t = -2 .8 ,/) < .01). However, criterion correlations of SOM were not higher compared with SOC and COG. Thus, theoretical expecta tions were not met in the case of symptom burden as strongest correlations were not observed for SOM. 3. In line w ith theoretical expectations from the AS literature, SOC scores were positively associated with fear of negative evaluation (r = .66, p < .01) and theoretically related IIP octants. As expected, the highest correlation of ASI-3 subscales with FNE was observed for SOC. The correlation of SOC with FNE was substantially higher than the correlation of SOM with FNE (t = -2 .8 ,p < .01). However, validity coefficients of SOC and COG did not differ. In Figure 2 , differential associations of ASI-3 subscales and IIP octants are presented. As expected, SOC scores were positively associ ated with Social Inhibition (FG, r = .29, p < .01) and Submissiveness (HI, r= A4,p < .05), and nega tively associated with Domineering (PA, r = -.2 8 , p < .01) and Intrusiveness (NO, r = -.18,/> < .01). ). COG was also correlated with depression symptoms as expected (r= .36,p < .01). Moreover, this correlation w ith the CES-D was substantially higher for COG com pared w ith SOM (t = -4 .5 , p < .01) and SOC (t = -2 .5 , p < .05) supporting differential validity of the ASI-3 subscales.
Besides statistical associations pertaining to the theo retical expectations reported above, further results concern ing the GAS score seem noteworthy. GAS correlated substantially with diverse measures of psychopathologyrelated constructs. Strong correlations were observed with 
Discussion
As indicated by prior research, the recently developed ASI-3 seems a promising candidate for a standard assess ment tool in AS research. However, results concerning the construct validity o f the ASI-3 in clinical samples are still sparse. In the study presented here, we sought to find com prehensive evidence on the usefulness o f the ASI-3 in clinical psychology research and applied settings. To this purpose, different aspects o f the construct validity o f the ASI-3 were tested in two clinical samples. The three-factorial structure o f the ASI-3 found in nonclinical student samples was corroborated in a sample o f patients with primary diag nosis o f anxiety or mood disorder. The subscale scores of the measure showed different patterns o f statistical relations with clinical diagnosis o f mental disorders, interpersonal functioning, body vigilance, and symptom burden which are consistent w ith AS literature. These results will be addressed in further detail below.
Because the structure o f the ASI-3 had been established in previous studies, we applied a confirmatory approach to test the factorial validity o f the ASI-3. The three-factor model proposed by Taylor et al. (2007) yielded an accept able fit to the data. All items had high and substantial load ings on three substantially correlated factors which measure somatic, social, and cognitive concerns about anxiety-related sensations. Correlations among factors w ere high and consistent with previous AS research (cf. Taylor et al., 2007 , Study 2) thereby supporting a global AS construct. An objection some researchers might have concerning model fit relates to residual correlations o f items within the Cognitive Concerns factor. However, these residual corre lations were because o f an overlap in item wording rather than conceptual reasons. They do not contradict the facto rial validity o f the ASI-3. Since residual correlations were not observed before, assuming sample specific influences seems reasonable in this case. Our results are in line with results from the initial validation study o f Taylor et al. (2007) and a validation study o f the German adaptation (Kemper et al., 2009) . Results presented by these authors support a three-factor hierarchic structure for nonclinical samples from North America, Spain, Mexico, France, the Netherlands, and Germany. According to our results, the three-factor hierarchic structure o f the ASI-3 seems to apply to clinical samples as well.
Further evidence supporting the construct validity o f the ASI-3 in clinical samples was gathered. We examined mean differences in ASI-3 scores between patients differing in clinical diagnosis and correlations between ASI-3 scales and other psychopathology-related constructs. Our pattern o f results was highly consistent with findings from AS research. Global AS scores o f patients allowed for a differ entiation o f patients with and without anxiety disorder diag nosis (cf. Deacon & Abramowitz, 2006; Olatunji & W olitzky-Taylor, 2009; Reiss et al., 1986) . Furthermore, the Global AS score showed a pattern o f relations to other constructs w ell known from the AS literature. Highest correlations were observed with measures o f anxiety and, lower but still substantial correlations emerged with mea sures o f body vigilance, symptom burden, and interpersonal functioning (cf. A rm strong et al., 2006; Deacon & Abramowitz, 2006; Naragon-Gainey, 2010; Zvolensky & Forsyth, 2002) . For ASI-3 subscales, expectations derived from the AS literature were also met. The Somatic Concerns subscale allowed for the differentiation o f patients with panic disorder and/or agoraphobia from patients with other anxiety disorders or nonanxiety disorders (cf. Reiss et al., 1986; Taylor et al., 2007) and subscale scores correlated w ith measures o f body vigilance and sym ptom burden (cf. Asmundson, Frombach, & Hadjistavropoulos, 1998; Osman et al., 2010; Richards & Bertram, 2000; Zvolensky & Forsyth, 2002) . For the Social Concerns subscale which captures the fear o f publicly observable anxiety reactions, substantial correlations with fear o f negative evaluation and interpersonal behavior-IIP octants-emerged as expected. We found convergent correlations for octants measuring shy, insecure, introverted, or socially avoidant behavior and discrim inant correlations for octants m easuring outgo ing, assertive, or dominant behavior (cf. Cox, Borger, Taylor, Fuentes, & Ross, 1999; Deacon & Abramowitz, 2006) . Concerning ASI-3 Cognitive Concerns, theoretical expectations derived from the AS literature were met as well. As expected, scores of patients w ith versus without an anxiety or mood disorder differed substantially in Cognitive Concerns (cf. Taylor et al., 2007) and subscale scores were substantially related to depression symptoms ( cf. NaragonGainey, 2010; Osman et al., 2010; Otto et al., 1995) .
A dding to the construct validity of the ASI-3 is the fact that different correlations w ith psychopathology-related constructs were found for ASI-3 subscales. For example, Somatic Concerns seems specifically related to vigilance for somatic symptoms. Correlation o f this subscale with body vigilance was substantially higher com pared with other ASI-3 subscales. Evidence for differential validity emerged w ith measures of symptom burden as well. But contrary to expectations, highest correlations were not observed w ith Somatic Concerns but with Cognitive Concerns. However, this unexpected finding may rather be due to an inappropriate expectation in the first place rather than a lack of validity of the Somatic Concerns subscale. Further evidence suggests differential validity of ASI-3 subscales. Social Concerns seems specifically related to fear of negative evaluation and thematically relevant IIP octants. Concerning Cognitive Concerns, highest and sub stantially different correlations were observed with depres sion symptoms compared w ith correlations with other subscales.
Taken together, we gathered considerable evidence supporting the construct validity of the ASI-3 by replicat ing (a) the three-factor hierarchic structure proposed by Taylor et al. (2007) , (b) statistical associations o f the ASI-3 scales w ith different psychopathology-related con structs reported in previous AS research, and (c) differ ences in ASI-3 subscale scores o f patients differing in prim ary clinical diagnosis w hile controlling for possible effects o f comorbidity.
A limiting factor of the present research was sample size. In future studies on the usefulness of the ASI-3 in clinical psychology research and practice, a larger sample size is preferable. In the research presented here, patients w ith certain disorders were undersampled, for example, patients w ith social phobia, generalized anxiety disorder, posttraumatic stress disorder, or hypochondriasis. Thus, differences in ASI-3 subscale scores for these groups of patients could not be tested. Furthermore, reference scores for patients w ith different anxiety or mood disorders are necessary for clinical assessment procedures. These scores should be sufficiently stable, that is, calculated from a large sample.
Due to these limitations, our study can only be seen as an important first step in testing the construct validity of the ASI-3 in clinical samples. To establish the ASI-3 as a useful and appropriate assessment tool in clinical psychol ogy research and practice, an extension of our work is highly encouraged.
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Notes
1. Relevance for treatm ent means that if a medical condition (e.g., heart disease) and a mental disorder (e.g., GAD) co-occur, the mental disorder was considered as relevant to psychotherapeu tic treatment. 
